RECOVER’s 2nd Round of Long COVID Clinical Trials Shows Progress… and Limitations
The RECOVER Initiative announces four more clinical trials for long COVID including low dose naltrexone, bariticinib, GLP-1 agonists, and stellate ganglion blockade.
A Wake-Up Call for ME/CFS? The Solriamfetol / Sunosi Trial Improves Daytime Fatigue and Cognition
The small Sunosi ME/CFS trial improved daytime fatigue, planning and organizing, and symptoms.
Tonmya is FDA Approved to Treat Fibromyalgia: CEO Seth Lederman Talks
Tonmya is the first FDA approved drug for use in fibromyalgia in 15 years. Seth Lederman, CEO of Tonix Pharmaceuticals, talked about how the drug was developed, what it does, and when it will become available.
An Inflammation Buster for Long COVID? The Bezisterim Clinical Trial
The new Bezisterin long COVID trials seeks to tamp down inflammation at the source and improve cognitive and fatigue.
Turning the Pain up in Fibromyalgia (and ME/CFS?): The Antibody-Mast Cell Connection
A study suggests that mast cell activation may be a key driver of chronic pain in fibromyalgia. Treatments are suggested.StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
